These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 23246791)
1. PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats. Brüel A; Vegger JB; Raffalt AC; Andersen JE; Thomsen JS Bone; 2013 Mar; 53(1):51-8. PubMed ID: 23246791 [TBL] [Abstract][Full Text] [Related]
2. Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats. Vegger JB; Nielsen ES; Brüel A; Thomsen JS Bone; 2014 Sep; 66():287-95. PubMed ID: 24970039 [TBL] [Abstract][Full Text] [Related]
3. Growth hormone mitigates loss of periosteal bone formation and muscle mass in disuse osteopenic rats. Grubbe MC; Thomsen JS; Nyengaard JR; Duruox M; Brüel A J Musculoskelet Neuronal Interact; 2014 Dec; 14(4):473-83. PubMed ID: 25524973 [TBL] [Abstract][Full Text] [Related]
4. PTH (1-34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats. Brent MB; Brüel A; Thomsen JS Bone; 2018 May; 110():244-253. PubMed ID: 29475111 [TBL] [Abstract][Full Text] [Related]
5. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats. Ma YF; Jee WS; Ke HZ; Lin BY; Liang XG; Li M; Yamamoto N J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Effect of Strontium Ranelate on Bone in Chemotherapy-Induced Osteopenic Rats via Increased Bone Volume and Reduced Bone Loss. Pei Y; Zheng K; Shang G; Wang Y; Wang W; Qiu E; Li S; Zhang X Biol Trace Elem Res; 2019 Feb; 187(2):472-481. PubMed ID: 29882118 [TBL] [Abstract][Full Text] [Related]
7. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment. Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210 [TBL] [Abstract][Full Text] [Related]
8. The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar. Brent MB; Thomsen JS; Brüel A Front Endocrinol (Lausanne); 2020; 11():588773. PubMed ID: 33162940 [TBL] [Abstract][Full Text] [Related]
9. Effects of alendronate and strontium ranelate on cancellous and cortical bone mass in glucocorticoid-treated adult rats. Sun P; Cai DH; Li QN; Chen H; Deng WM; He L; Yang L Calcif Tissue Int; 2010 Jun; 86(6):495-501. PubMed ID: 20390406 [TBL] [Abstract][Full Text] [Related]
10. Systemic Treatment with Strontium Ranelate Does Not Influence the Healing of Femoral Mid-shaft Defects in Rats. Vegger JB; Brüel A; Sørensen TG; Thomsen JS Calcif Tissue Int; 2016 Feb; 98(2):206-14. PubMed ID: 26543033 [TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone. Ma Y; Jee WS; Yuan Z; Wei W; Chen H; Pun S; Liang H; Lin C J Bone Miner Res; 1999 Mar; 14(3):439-48. PubMed ID: 10027909 [TBL] [Abstract][Full Text] [Related]
12. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. Ammann P; Shen V; Robin B; Mauras Y; Bonjour JP; Rizzoli R J Bone Miner Res; 2004 Dec; 19(12):2012-20. PubMed ID: 15537445 [TBL] [Abstract][Full Text] [Related]
13. Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice. Brent MB; Lodberg A; Bromer FD; van der Eerden BCJ; Eijken M; Brüel A; Thomsen JS Bone; 2021 Jan; 142():115692. PubMed ID: 33069923 [TBL] [Abstract][Full Text] [Related]
14. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture. Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345 [TBL] [Abstract][Full Text] [Related]
15. Effect of strontium ranelate on bone remodeling. Rodríguez J; Escudero ND; Mandalunis PM Acta Odontol Latinoam; 2012; 25(2):208-13. PubMed ID: 23230643 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis. Recker RR; Marin F; Ish-Shalom S; Möricke R; Hawkins F; Kapetanos G; de la Peña MP; Kekow J; Farrerons J; Sanz B; Oertel H; Stepan J J Bone Miner Res; 2009 Aug; 24(8):1358-68. PubMed ID: 19338452 [TBL] [Abstract][Full Text] [Related]
17. Loss of bone strength is dependent on skeletal site in disuse osteoporosis in rats. Thomsen JS; Christensen LL; Vegger JB; Nyengaard JR; Brüel A Calcif Tissue Int; 2012 Apr; 90(4):294-306. PubMed ID: 22354132 [TBL] [Abstract][Full Text] [Related]
18. [Effect of human PTH on steroid-induced osteopenia: a histomorphometric study of decalcified and undecalcified trabecular bone sections in rat]. Unoki E Nihon Seikeigeka Gakkai Zasshi; 1995 Oct; 69(10):1064-75. PubMed ID: 8551091 [TBL] [Abstract][Full Text] [Related]
19. Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats. Ejersted C; Andreassen TT; Oxlund H; Jørgensen PH; Bak B; Häggblad J; Tørring O; Nilsson MH J Bone Miner Res; 1993 Sep; 8(9):1097-101. PubMed ID: 8237479 [TBL] [Abstract][Full Text] [Related]
20. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]